900 related articles for article (PubMed ID: 9489614)
21. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
Lecci A; Capriati A; Altamura M; Maggi CA
Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the tachykinin receptors involved in spinal and supraspinal cardiovascular regulation.
Couture R; Picard P; Poulat P; Prat A
Can J Physiol Pharmacol; 1995 Jul; 73(7):892-902. PubMed ID: 8846427
[TBL] [Abstract][Full Text] [Related]
23. Tachykinin receptors in rabbit airways--characterization by functional, autoradiographic and binding studies.
Black JL; Diment LM; Alouan LA; Johnson PR; Armour CL; Badgery-Parker T; Burcher E
Br J Pharmacol; 1992 Oct; 107(2):429-36. PubMed ID: 1384914
[TBL] [Abstract][Full Text] [Related]
24. Renal effects of intracerebroventricularly injected tachykinins in the conscious saline-loaded rat: receptor characterization.
Yuan YD; Couture R
Br J Pharmacol; 1997 Mar; 120(5):785-96. PubMed ID: 9138683
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
26. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
27. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
[TBL] [Abstract][Full Text] [Related]
28. Tachykinins and tachykinin receptors in human uterus.
Patak E; Candenas ML; Pennefather JN; Ziccone S; Lilley A; Martín JD; Flores C; Mantecón AG; Story ME; Pinto FM
Br J Pharmacol; 2003 Jun; 139(3):523-32. PubMed ID: 12788812
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms mediating substance P-induced contraction in the rat iris in vitro.
Grumann-Júnior A; Dias MA; Alves RV; Boteon JE; Calixto JB
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1861-70. PubMed ID: 10845610
[TBL] [Abstract][Full Text] [Related]
30. Potencies of agonists acting at tachykinin receptors in the oestrogen-primed rat uterus: effects of peptidase inhibitors.
Fisher L; Pennefather JN
Eur J Pharmacol; 1997 Sep; 335(2-3):221-6. PubMed ID: 9369377
[TBL] [Abstract][Full Text] [Related]
31. Tachykinin receptor expression and function in human esophageal smooth muscle.
Kovac JR; Chrones T; Preiksaitis HG; Sims SM
J Pharmacol Exp Ther; 2006 Aug; 318(2):513-20. PubMed ID: 16714401
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
33. Increased blocking activity of combined tachykinin NK1- and NK2-receptor antagonists on tachykinergic bronchomotor responses in the guinea-pig.
Corboz MR; Fernandez X; Rizzo CA; Tozzi S; Monahan ME; Hey JA
Auton Autacoid Pharmacol; 2003 Feb; 23(1):79-93. PubMed ID: 14565542
[TBL] [Abstract][Full Text] [Related]
34. Neurokinin A-induced vasoconstriction and muscular contraction in the rat isolated stomach: mediation by distinct and unusual neurokinin2 receptors.
Lippe I; Wachter CH; Holzer P
J Pharmacol Exp Ther; 1997 Jun; 281(3):1294-302. PubMed ID: 9190865
[TBL] [Abstract][Full Text] [Related]
35. Tachykinin receptors mediating non-cholinergic contraction of the guinea-pig isolated main bronchus in response to field stimulation.
Heavey ML; Lan WA; Pennefather JN
Clin Exp Pharmacol Physiol; 1997; 24(9-10):673-9. PubMed ID: 9315368
[TBL] [Abstract][Full Text] [Related]
36. The tachykinin receptors inducing contractile responses of canine ileum circular muscle.
Daniel EE; Parrish MB; Watson EG; Fox-Threlkeld JE; Regoli D; Rainsford KD
Am J Physiol; 1995 Jan; 268(1 Pt 1):G161-70. PubMed ID: 7530911
[TBL] [Abstract][Full Text] [Related]
37. Effects of tachykinins on uterine smooth muscle.
Patak EN; Pennefather JN; Story ME
Clin Exp Pharmacol Physiol; 2000 Nov; 27(11):922-7. PubMed ID: 11071311
[TBL] [Abstract][Full Text] [Related]
38. MEN 11420, a potent and selective tachykinin NK2 receptor antagonist in the guinea-pig and human colon.
Santicioli P; Giuliani S; Patacchini R; Tramontana M; Criscuoli M; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):678-88. PubMed ID: 9402049
[TBL] [Abstract][Full Text] [Related]
39. Tachykinins contract the circular muscle of the human esophageal body in vitro via NK2 receptors.
Huber O; Bertrand C; Bunnett NW; Pellegrini CA; Nadel JA; Debas HT; Geppetti P
Gastroenterology; 1993 Oct; 105(4):981-7. PubMed ID: 7691676
[TBL] [Abstract][Full Text] [Related]
40. Tachykinin NK-2 receptors in child urinary bladder.
Zeng XP; Burcher E
J Urol; 1996 Mar; 155(3):1104-7. PubMed ID: 8583573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
